Movie Industry

Jung Hae-in Skips 'Agami' Premiere… Unrelated to Controversy Over Ha-young Being a Descendant of Pro-Japanese Collaborators

Voicing the Role of the Main Character, Gon "We have a pre-scheduled filming schedule."

KIM HYUNSIK
2026-08-17 15:03:29
[Edaily Starin KIM HYUNSIK Reporter] Actor Jung Hae-in will not attend the press screening for the animated film "Agami."
Jung Hae-in (Photo: Netflix)
According to his agency, FNC Entertainment (FNC), on the 17th, Jung Hae-in will not attend the press screening for “Agami” scheduled for the 26th.
“Agami” is based on the novel of the same name by author Koo Byung-mo. It tells the story of “Gon,” the only child in a world where gills have emerged. Along with Jung Hae-in, who voices the protagonist Gon, Kang Ha-neul, Lee Chung-ah, Yoo Jae-myung, and Kim Sun-young also participated in the film by providing voice acting.
Previously, Jung Hae-in was scheduled to hold a press interview on the 14th for the Netflix series “Such a Shitty Love,” but canceled the event after his co-lead, Ha Young, became embroiled in controversy over allegations that she is a descendant of pro-Japanese collaborators.
Amid this, when news broke that Jung Hae-in would not attend the press screening for “Agami,” some speculated that it was due to the fallout from the Ha Young controversy. In response, his agency told Edaily that day, “He will be absent due to a pre-scheduled filming schedule.”
Meanwhile, *Such a Shitty Love* was released on Netflix on the 7th. *Agami* is set to open in theaters on the 9th of next month.

Economy

Corporation

IT·Science

Economy

[Market In] Far Exceeding the Target Amount by 10 Times… 2.1 Trillion Won in “Lump-Sum Funds” Flows into NH INVESTMENT & SECURITIES Corporate Bonds

NH INVESTMENT & SECURITIES(005940)The company successfully secured its target issuance amount by raising funds exceeding 10 times the target amount during the bookbuilding process for its corporate bo…
2026-09-08 18:00:03

Corporation

Neopharm CO., LTD., on a "Record-Breaking Streak of Earnings," Expands into a Global Derma-Beauty Brand

Neopharm CO., LTD.(092730), a South Korean derma-beauty specialist, is seeking to expand into a global derma-beauty brand by leveraging “Atopam,” a skincare brand specializing in sensitive skin condit…
2026-09-08 17:48:06

IT·Science

“Korea’s 44th Domestically Developed New Drug,” Latica, Launched… Taking on the 500 Billion Won Dry Eye Market

(Graphic: ChatGPT) A domestically developed treatment with a new mechanism of action is set to enter the Korean dry eye market, which has long been dominated by artificial tears. This follows the …
2026-09-08 17:11:02